CLB

Based on Core Laboratories N.V.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.

What does Core Laboratories do?

Core Laboratories provides reservoir description and production enhancement services to oil and gas producers in about 50 countries. It analyzes reservoir rock, fluid, and gas samples and offers well completion diagnostics, stimulation products, and enhanced oil recovery monitoring to help clients improve production from existing fields.

Does CLB pay dividends?

Yes, Core Laboratories pays a regular dividend. The company has historically returned cash to shareholders through dividends, though the payout can be sensitive to energy market cycles. Investors should check the current dividend rate and payment schedule on Core Laboratories' investor relations page.

When does CLB report earnings?

Core Laboratories reports on a quarterly cadence, as is standard for US-listed companies. For the exact timing of upcoming earnings releases, refer to the company's investor relations page or a financial calendar service.

Is CLB a good stock to buy?

The UQS Score rates CLB as Below Average, driven primarily by Weak ratings on the Moat and Growth pillars. Quality, Risk, and Valuation all sit at Neutral. Whether that profile fits your portfolio depends on your risk tolerance and investment goals — the full pillar breakdown is available to Pro members.

Is CLB overvalued?

CLB's Valuation pillar is rated Neutral, suggesting the stock is neither clearly cheap nor obviously expensive relative to its fundamentals at the time of scoring. Investors seeking a deeper look at the underlying valuation metrics can access the full analysis through a Pro account.

How does CLB compare to its competitors?

Core Laboratories occupies a niche position focused on laboratory-based reservoir science and production diagnostics. Peers like Forum Energy Technologies and HMH Holding lean more toward hardware and drilling tools, while Total Energy Services offers a broader operational services mix. CLB's differentiation rests on its analytical depth rather than equipment scale.

What is CLB's market cap bracket?

Core Laboratories is classified as a small-cap company. This places it in a segment of the market that can offer higher growth potential but also carries greater volatility and liquidity risk compared to large- or mega-cap energy services peers.

Who founded Core Laboratories?

Core Laboratories traces its operational roots to 1936, though the current corporate entity was incorporated in 1995. Detailed founding history is publicly available through the company's official communications and investor relations materials.

Is CLB a long-term quality indicator stock?

Based on the UQS framework, CLB's Below Average overall score — anchored by Weak Moat and Growth ratings — suggests limited structural advantages for long-term compounding. The Neutral Quality and Risk ratings indicate the business is functional but not a standout on durability metrics. Pro members can review the full pillar detail to assess long-term fit.

What is the main competitive advantage of Core Laboratories?

Core Laboratories' edge lies in its specialized laboratory capabilities and decades of proprietary reservoir data. However, the UQS Moat pillar rates this advantage as Weak, suggesting that competitive barriers may not be strong enough to consistently defend margins or market share against peers and broader industry pressures.

What sector does CLB belong to?

CLB operates in the Energy sector, specifically within oilfield services. It serves upstream oil and gas producers rather than producing hydrocarbons itself, making its revenue tied to client exploration and production budgets rather than commodity prices directly.

Core Laboratories N.V. has average quality metrics, with room for improvement in margins or capital efficiency.

Core Laboratories N.V. faces growth headwinds with declining or stagnant revenue trends.

Core Laboratories N.V. maintains a reasonable risk profile with manageable debt levels.

Core Laboratories N.V. trades at a reasonable valuation with decent earnings yield and FCF multiples.

Core Laboratories N.V. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for CLB.

The UQS (Unified Quality Score) for Core Laboratories N.V. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.

Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.

Moat (25%) assesses Core Laboratories N.V.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.

Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.

Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.

Valuation (15%) measures whether Core Laboratories N.V. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.

Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.